Cloudbreak Pharma Inc. (2592)
Market Closed
12 Aug, 08:00
HKEX HKEX Primary 1. 19
HKD -0.05
-4.0323%
6.99B Market Cap
- P/E Ratio
- Div Yield
185,000 Volume
- Eps
1.24 HKD
Previous Close Want to track 2592 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cloudbreak Pharma Inc. (2592) Statistics
Valuation metrics
Market Cap 6.99B
Enterprise value 8.21B
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 4,444.73
Price/Book (mrq) 2.34
Enterprise Value/Revenue 4,145.42
Enterprise Value/EBITDA -9.81
Overview
Shares outstanding 844.57M
Float 303.62M
Shares short -
% Held by insiders 0.49%
% Held by institutions 0.06%
Average volume (10 days) 494K
Average volume (90 days) 1.25M
Price summary
52-Week low 0.9
52-Week high 9.58
Beta -
50-Day moving average 1.62
200-Day moving average 3.72
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -329.57%
Operational effectiveness
Return on assets -1.26%
Return on equity -1.12%
Income Statement
Revenue (ttm) 1.98M
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -0.98%
Gross profit (ttm) 1.98M
EBITDA -837.34M
Net income to common (ttm) -529.9M
Diluted EPS (ttm) -0.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 456.99M
Total cash per share (mrq) 0.07
Total debt (mrq) 5.97M
Total Debt/Equity (mrq) 1.26
Current ratio (mrq) 10.68%
Book value per share (mrq) 0.56
Cash Flow
Cash flow statement -403.64M
Levered free cash flow (LFCF) -91.06M
